Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   ACTAVIS
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-24
ACTAVIS
Dec-18
AUROBINDO PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,17716,355-   
Low Rs51710,971-   
Sales per share (Unadj.) Rs495.04,011.8-  
Earnings per share (Unadj.) Rs54.1-1,292.2-  
Cash flow per share (Unadj.) Rs80.1422.8-  
Dividends per share (Unadj.) Rs4.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs509.316,546.7-  
Shares outstanding (eoy) m585.94332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.73.4 50.2%   
Avg P/E ratio x15.7-10.6 -148.1%  
P/CF ratio (eoy) x10.632.3 32.7%  
Price / Book Value ratio x1.70.8 201.4%  
Dividend payout %8.30-   
Avg Mkt Cap Rs m496,2904,544,200 10.9%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m39,2290-   
Avg. sales/employee Rs Th078,953.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,431.0-  
INCOME DATA
Net Sales Rs m290,0191,334,317 21.7%  
Other income Rs m5,57425,517 21.8%   
Total revenues Rs m295,5931,359,834 21.7%   
Gross profit Rs m56,34034,966 161.1%  
Depreciation Rs m15,217570,392 2.7%   
Interest Rs m2,89776,998 3.8%   
Profit before tax Rs m43,800-586,907 -7.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0149,685 0.0%   
Tax Rs m12,110-7,438 -162.8%   
Profit after tax Rs m31,690-429,784 -7.4%  
Gross profit margin %19.42.6 741.3%  
Effective tax rate %27.61.3 2,181.8%   
Net profit margin %10.9-32.2 -33.9%  
BALANCE SHEET DATA
Current assets Rs m237,719547,267 43.4%   
Current liabilities Rs m121,991484,131 25.2%   
Net working cap to sales %39.94.7 843.3%  
Current ratio x1.91.1 172.4%  
Inventory Days Days1720 86.3%  
Debtors Days Days6166 91.4%  
Net fixed assets Rs m196,532151,037 130.1%   
Share capital Rs m5860-   
"Free" reserves Rs m297,8420-   
Net worth Rs m298,4285,503,435 5.4%   
Long term debt Rs m21,3491,937,959 1.1%   
Total assets Rs m438,5898,603,122 5.1%  
Interest coverage x16.1-6.6 -243.4%   
Debt to equity ratio x0.10.4 20.3%  
Sales to assets ratio x0.70.2 426.3%   
Return on assets %7.9-4.1 -192.3%  
Return on equity %10.6-7.8 -136.0%  
Return on capital %14.6-4.8 -301.7%  
Exports to sales %32.90-   
Imports to sales %11.50-   
Net fx Rs m60,1520-   
CASH FLOW
From Operations Rs m24,345476,701 5.1%  
From Investments Rs m-42,560261,885 -16.3%  
From Financial Activity Rs m8,004-818,162 -1.0%  
Net Cashflow Rs m-10,068-79,178 12.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 84.52 Rs / USD

Compare AUROBINDO PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare AUROBINDO PHARMA With: SAKAR HEALTHCARE   MEDICAMEN ORGANICS LTD.  GRANULES INDIA  NECTAR LIFESCIENCE  TYCHE INDUSTRIES  



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.